Compare NMTC & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NMTC | BEAT |
|---|---|---|
| Founded | 2009 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.2M | 27.7M |
| IPO Year | 2010 | 2021 |
| Metric | NMTC | BEAT |
|---|---|---|
| Price | $1.85 | $0.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $11.90 | $5.63 |
| AVG Volume (30 Days) | 48.2K | ★ 496.2K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.43 | 15.07 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,097,692.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $31.90 | $315.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 163.47 | N/A |
| 52 Week Low | $0.55 | $0.48 |
| 52 Week High | $5.40 | $4.00 |
| Indicator | NMTC | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 43.40 | 56.11 |
| Support Level | $0.66 | $0.61 |
| Resistance Level | $1.98 | $0.70 |
| Average True Range (ATR) | 0.21 | 0.04 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 77.14 | 88.94 |
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.